With India's capacity to manufacture medicines at competitive prices and drugs worth $80 million going off-patents soon, there is a big opportunity for investment in the drug manufacturing sector, Health Minister Ghulam Nabi Azad said on January 9, reported by the Business Standard, The Hindu and other local media.
"The government has already cleared the desk by streamlining and strengthening of the regulatory framework with international credence," he said, addressing delegates at the Pravasi Bhartiya Divas in New Delhi.
Mr Azad noted that the drug regulatory framework in the country is in the process of modernization and strengthening. "Regulatory norms and procedures are being harmonised with the international requirements like that of international conference on harmonisation taskforce," he said.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze